Select your location to view local American Lung Association events and news near you.
Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...
After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...
KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected ...
Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.
Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...
CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...
At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
Nivolumab plus AVD significantly improves PFS compared to brentuximab vedotin plus AVD in advanced-stage classic Hodgkin lymphoma, with a 91% vs 82% 3-year PFS rate. The PFS benefit of nivolumab plus ...
Dealing with an infection isn't as straightforward as simply killing the pathogen. The body also needs to carefully steer and ...
In this video, Hamza Hassan, MD, assistant professor of oncology at Roswell Park Comprehensive Cancer Center, discusses the second-line of treatment for this case. Editor's note: The following is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback